by John Nycz | May 28, 2020 | Diagnostics, Healthcare Legislation
Diagnostic Testing for Public Health Labs Act of 2020 & Rapid Testing for Communities Act of 2020 From Diagnostic Testing for Public Health Labs Act of 2020 Targets entities: hospital; a primary care facility; a clinic; physician; or another type health...
by John Nycz | May 22, 2020 | Diagnostics
“66% of surveyed healthcare workers reported shortages of respirator masks at their workplace” Healthcare Workers Report Shortages into May A Washington Post-Ipsos poll found 66% of surveyed healthcare workers reported shortages of respirator masks at...
by John Nycz | May 16, 2020 | Diagnostics
“To date, no human reinfections have been observed.” Will COVID-19 Produce a Durable Immune Response? The latest from CDC researchers and physicians as published May 11, 2020 in JAMA. In spite of no known reinfections, the body of evidence is still...
by John Nycz | May 14, 2020 | Diagnostics
U.S. based physicians and scientists from 57 institutions and 46 states have banded together. On their own. Here’s the leadership — it’s impressive: COVID-19 Convalescent Plasma Project (CCPP19) Leadership Group Arturo Casadevall MD, PhD (Chair),...
by John Nycz | May 7, 2020 | Diagnostics
As we at the FDA have said before, every step we have taken in our approach to COVID-19 testing has been a careful balancing of risks and benefits – all done to anticipate and meet continuing and evolving public health needs as we combat this virus. That’s why today...
Recent Comments